1. Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients;Agha;medRxiv,2021
2. An affordable anti-SARS-COV-2 spike protein ELISA test for early detection of IgG seroconversion suited for large-scale surveillance studies in low-income countries;Alvim;medRxiv,2020
3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;New Engl. J. Med.,2020
4. COVID-19 and cancer: current challenges and perspectives;Bakouny;Cancer Cell,2020
5. Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors;Barrière;Ann. Oncol.,2021